Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies.

Baumgartner, Daniel; Mazanec, Radim; Hanzalová, Jitka

Baumgartner, Daniel; Mazanec, Radim; Hanzalová, Jitka.

Afiliação

Baumgartner D; Neuromuscular Centre, Department of Neurology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic. daniel.baumgartner@fnmotol.cz.
Mazanec R; Neuromuscular Centre, Department of Neurology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic.
Hanzalová J; Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic.

J Neurol ; 270(3): 1600-1614, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36456758

Assuntos

Doença dos Neurônios Motores; Radiculopatia; Doenças da Medula Espinal; Humanos; Estudos Retrospectivos; Filamentos Intermediários; Biomarcadores; Proteínas de Neurofilamentos; Doença dos Neurônios Motores/diagnóstico; Fenótipo

Palavras-chave

Amyotrophic lateral sclerosis; Biomarker; Cerebrospinal fluid; Motor neuron disease; Neurofilament

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiculopatia / Doenças da Medula Espinal / Doença dos Neurônios Motores Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google